RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 103 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $200,000 | – | 12,695 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Trellus Management Company, LLC | 63,500 | $1,003,000 | 1.13% |
Broadfin Capital, LLC | 1,319,883 | $20,841,000 | 1.12% |
BAILARD, INC. | 160,000 | $2,526,000 | 0.39% |
Birchview Capital, LP | 46,000 | $726,000 | 0.38% |
HIGHLAND CAPITAL MANAGEMENT LP | 1,182,167 | $18,666,000 | 0.38% |
Rock Springs Capital Management LP | 305,000 | $4,816,000 | 0.35% |
SPHERA FUNDS MANAGEMENT LTD. | 206,500 | $3,261,000 | 0.32% |
GLOBEFLEX CAPITAL L P | 109,771 | $1,733,000 | 0.32% |
GROUP ONE TRADING, L.P. | 1,319,766 | $20,839,000 | 0.29% |
Perceptive Advisors | 264,204 | $4,172,000 | 0.25% |